Effects of Sacubitril/Valsartan on biomarkers of fibrosis and inflammation in patients with heart failure with reduced ejection fraction

被引：0
|
作者：
Giovanni Battista Bolla
Antonella Fedele
Andrea Faggiano
Carla Sala
Gloria Santangelo
Stefano Carugo
机构：
[1] University of Milan and Fondazione IRCCS Ca’ GrandaOspedale Maggiore Policlinico,Department of Clinical Sciences and Community Health
[2] Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico,Cardiology Unit, Internal Medicine Department
[3] University of Milan,Division of Cardiology, Department of Health Sciences, San Paolo Hospital
来源：
BMC Cardiovascular Disorders | / 22卷
关键词：
Heart failure; Sacubitril/Valsartan; Biomarkers; Fibrosis; Left ventricular ejection fraction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] The efficacy and safety of sacubitril/valsartan in heart failure with reduced ejection fraction patients with hypotension
    Yu Takigami
    Shunsuke Ishii
    Yuko Eda
    Mayu Yazaki
    Teppei Fujita
    Yuichiro Iida
    Yuki Ikeda
    Takeru Nabeta
    Jun Oikawa
    Toshimi Koitabashi
    Junya Ako
    Heart and Vessels, 2023, 38 : 1337 - 1343
  • [22] Effects of sacubitril-valsartan on central and obstructive apneas in heart failure patients with reduced ejection fraction
    Youmeng Wang
    Roberto Fernandes Branco
    Matthew Salanitro
    Thomas Penzel
    Christoph Schöbel
    Sleep and Breathing, 2023, 27 : 283 - 289
  • [23] Effects of sacubitril-valsartan on central and obstructive apneas in heart failure patients with reduced ejection fraction
    Wang, Youmeng
    Branco, Roberto Fernandes
    Salanitro, Matthew
    Penzel, Thomas
    Schobel, Christoph
    SLEEP AND BREATHING, 2023, 27 (01) : 283 - 289
  • [24] Effects of Sacubitril/Valsartan on pressure-volume relationship in patients with heart failure and reduced ejection fraction
    Stegmann, T.
    Parentin, L.
    Schirmer, S. H.
    Hagendorff, A.
    Laufs, U.
    Lavall, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 28 - 28
  • [25] Effects of Sacubitril/Valsartan on the Right Ventricular Arterial Coupling in Patients with Heart Failure with Reduced Ejection Fraction
    Masarone, Daniele
    Errigo, Vittoria
    Melillo, Enrico
    Valente, Fabio
    Gravino, Rita
    Verrengia, Marina
    Ammendola, Ernesto
    Vastarella, Rossella
    Pacileo, Giuseppe
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (10) : 1 - 10
  • [26] Early effects of Sacubitril/valsartan on exercise tolerance in patients with heart failure with reduced ejection fraction.
    Vitale, G.
    Sarullo, S.
    Nugara, C.
    Maria Sarullo, F. M. Filippo
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 240 - 241
  • [27] The effects of Sacubitril-Valsartan on ICD indication in patients with heart failure with reduced ejection fraction.
    Mariana Tinoco, M.
    Cardoso, F.
    Dias, G.
    Pereira, T.
    Faria, B.
    Almeida, F.
    Leite, S.
    Lourenco, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 112 - 113
  • [28] Sacubitril/valsartan attenuates myocardial inflammation, hypertrophy, and fibrosis in rats with heart failure with preserved ejection fraction
    Shi, Yu Jiao
    Yang, Chen Guang
    Qiao, Wen Bo
    Liu, Yong Cheng
    Liu, Si Yu
    Dong, Guo Ju
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 961
  • [29] Heart Failure Duration and Mechanistic Efficacy of Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction
    Mohebi, Reza
    Liu, Yuxi
    Felker, G. Michael
    Prescott, Margaret F.
    Ward, Jonathan H.
    Pina, Ileana L.
    Butler, Javed
    Solomon, Scott D.
    Januzzi, James L.
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (12) : 1673 - 1682
  • [30] Economic evaluation of sacubitril/valsartan for the treatment of heart failure with reduced ejection fraction
    Stafylas, P.
    Farmakis, D.
    Giamouzis, G.
    Hatzikou, M.
    Kourlaba, G.
    Papatsouma, I.
    Maniadakis, N.
    EUROPEAN HEART JOURNAL, 2016, 37 : 730 - 731
12345